Modified Coagulation Factor Vila With Extended Half-Life

Patent No. EP1984503 (titled "Modified Coagulation Factor Vila With Extended Half-Life") was filed by CSL Behring GmbH on Feb 3, 2007. The application was issued on Aug 15, 2018.

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
KONIG SZYNKA TILMANN VON RENESSEApr 9, 2015HEMSATH

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP1984503

CSL BEHRING GMBH
Application Number
EP07703248A
Filing Date
Feb 3, 2007
Status
Patent Maintained As Amended
Jul 13, 2018
Publication Date
Aug 15, 2018